Active, not recruiting
Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
NCT04166565
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Plasmacytoma, +13 more
- Locations
-
- University of Athens Athens, Greece
- Anticancer Hospital of Thessaloniki Thessaloniki, Greece
- University of Bologna Bologna, Italy
- Univerity of Turin Torino, Italy